Jingchao Xu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 4
- Cancer, Hypoxia, and Metabolism 2
- MicroRNA in disease regulation 2
- Hepatology top 10%
-
- RNA modifications and cancer 3
- Circular RNAs in diseases 3
- Cell death mechanisms and regulation 2
-
- Cytokine Signaling Pathways and Interactions 2
-
- Ferroptosis and cancer prognosis 3
- Co-authors
- Yongfu ZhaoLeilei LiangGuangzhi WangGaoran XuJia LiDong CuiMeng WangNing Zhang
In The Last Decade
Jingchao Xu
19 papers receiving 681 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 373
- Hepatology 54
- Molecular Biology 440
- Immunology 99
- Oncology 116
Countries citing papers authored by Jingchao Xu
This map shows the geographic impact of Jingchao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingchao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingchao Xu more than expected).
Fields of papers citing papers by Jingchao Xu
This network shows the impact of papers produced by Jingchao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingchao Xu. The network helps show where Jingchao Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingchao Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 30 | |
| 4 | 2023 | 38 | |
| 5 | 2023 | 31 | |
| 6 | 2023 | 12 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 57 | |
| 10 | 2020 | 120 | |
| 11 | 2019 | 2 | |
| 12 | 2018 | 26 | |
| 13 | 2018 | 105 | |
| 14 | 2018 | 29 | |
| 15 | 2017 | 99 | |
| 16 | 2016 | 34 | |
| 17 | 2016 | 37 | |
| 18 | 2016 | 27 | |
| 19 | Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects. | 2015 | 17 |
| 20 | 2013 | 32 |
About Jingchao Xu
Jingchao Xu is a scholar working on Cancer Research, Internal Medicine and Oncology, having authored 20 papers that have together received 703 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Ferroptosis and cancer prognosis (3 papers), RNA modifications and cancer (3 papers), Circular RNAs in diseases (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), MicroRNA in disease regulation (2 papers), Cell death mechanisms and regulation (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Cancer Research (373 citations), Hepatology (54 citations) and Molecular Biology (440 citations). Jingchao Xu has collaborated with scholars based in China and Japan. Frequent co-authors include Yongfu Zhao, Leilei Liang, Guangzhi Wang, Gaoran Xu, Jia Li, Dong Cui, Meng Wang, Ning Zhang, Yiran Huang and Yujia Shan. Their work appears in journals such as Cell Death and Disease, Aging, Oncogenesis, Tumor Biology and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.